Advanced Hemorrhage Control Systems

Publication ID: 24-11857443_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Advanced Hemorrhage Control Systems,” Published Technical Disclosure No. 24-11857443_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857443_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,443.

Summary of the Inventive Concept

A next-generation hemorrhage control system that leverages AI, shape-memory alloys, and micro-robotics to revolutionize the treatment of catastrophic bleeding.

Background and Problem Solved

The original patent's automated retrievable hemorrhage control system, while effective, has limitations in terms of adaptability, real-time monitoring, and multi-site bleeding control. The new inventive concept addresses these limitations by introducing advanced materials, AI-driven analytics, and swarm robotics to provide a more comprehensive and effective solution.

Detailed Description of the Inventive Concept

The advanced hemorrhage control system comprises a stent graft device with an adaptive shape-memory alloy that adjusts to the blood vessel's diameter, a neural network-based controller that predicts and prevents hemorrhage, and a real-time monitoring system that integrates AI-driven analytics with sensor data. The system also includes a swarm of micro-robots that navigate to the site of bleeding and deploy a nanofiber-based hemostatic agent, and a centralized command center that coordinates the micro-robots' actions. Additionally, the system features a modular, implantable device for controlling bleeding from multiple sites, comprising a series of interconnected stent graft modules, each with its own AI-powered flow control system, and a user interface for real-time monitoring and adjustment.

Novelty and Inventive Step

The new inventive concept introduces several novel features, including the use of adaptive shape-memory alloys, AI-driven analytics, swarm robotics, and bio-inspired, shape-shifting materials. These advancements provide a significant improvement over the original patent, enabling real-time monitoring, multi-site bleeding control, and more effective hemorrhage prevention.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different materials, such as hydrogels or polymers, or variations in the design of the stent graft device, such as the use of different shapes or geometries. Additionally, the system could be adapted for use in different medical contexts, such as trauma care or surgical procedures.

Potential Commercial Applications and Market

The advanced hemorrhage control system has significant commercial potential in the medical device industry, particularly in the areas of trauma care, cardiovascular surgery, and emergency medicine. The system's ability to provide real-time monitoring, multi-site bleeding control, and more effective hemorrhage prevention makes it an attractive solution for hospitals and medical centers.

CPC Classifications

SectionClassGroup
A A61 A61F2/958
A A61 A61B5/02
A A61 A61B5/02042
A A61 A61B5/6862
A A61 A61B17/12036
A A61 A61B17/12045
A A61 A61B17/12109
A A61 A61B17/12118
A A61 A61B17/12136
A A61 A61F2/07
A A61 A61B5/024
A A61 A61B5/02055
A A61 A61B5/02158
A A61 A61B5/14539
A A61 A61B5/14542
A A61 A61B5/6853
A A61 A61B2017/00017
A A61 A61B2017/00022
A A61 A61F2/9522
A A61 A61F2002/061
A A61 A61F2002/077
A A61 A61F2002/9528
A A61 A61F2230/0067
A A61 A61F2230/0069
A A61 A61F2250/001
A A61 A61F2250/0002
A A61 A61F2250/0003
A A61 A61F2250/0024
A A61 A61F2250/0039
A A61 A61F2250/0059
A A61 A61F2250/0069
A A61 A61F2250/0096

Field of Art

Medical device engineering, specifically endovascular hemorrhage control systems, involving expertise in biomedical engineering, interventional radiology, materials science, and advanced sensor technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degrees, experienced in medical device design, familiar with vascular intervention techniques, sensor integration, and adaptive medical technologies with knowledge of materials engineering and AI-assisted medical systems

Obviousness Rationale

A PHOSITA would recognize that the PTD's proposed variations represent predictable technological extensions of the source patent's core hemorrhage control system, utilizing known engineering techniques such as adaptive materials, integrated sensors, and AI-driven monitoring to enhance existing stent graft technologies. The proposed modifications represent incremental improvements using standard design approaches within the medical device engineering domain. The combination of shape-memory alloys, neural network controllers, and modular design would be considered obvious evolutionary developments for a skilled practitioner seeking to optimize hemorrhage control systems.

Obvious Combinations & Variations

Source Patent Element
Stent graft with expandable tubular metallic frame and covering material
PTD Variation
Adaptive shape-memory alloy frame that adjusts to blood vessel diameter
Obviousness Reasoning
Material substitution is a standard design approach, and shape-memory alloys are well-known in medical device engineering for adaptive structural properties
Source Patent Element
Sensors for detecting fluid pressure and blood flow rate
PTD Variation
Neural network-based controller integrating AI-driven analytics with sensor data
Obviousness Reasoning
Combining sensor technologies with machine learning is a predictable enhancement in medical monitoring systems, representing an obvious technological progression
Source Patent Element
Endovascular device with multiple integrated components
PTD Variation
Modular stent graft system with interconnected modules and individual AI-powered flow control
Obviousness Reasoning
Modular design and distributed control systems are standard engineering approaches for increasing system flexibility and performance
Source Patent Element
Stent graft with sensors for pressure and flow detection
PTD Variation
Micro-robotic system with centralized command center for targeted hemostatic agent deployment
Obviousness Reasoning
Extending sensor-based monitoring to active intervention is a logical and predictable technological progression in medical device design
Source Patent Element
Stent graft with tapered diametrical configuration
PTD Variation
Bio-inspired, shape-shifting device using hydrogel materials responsive to temperature and pH changes
Obviousness Reasoning
Material substitution and biomimetic design represent standard engineering approaches for improving medical device performance
35 U.S.C. § 103 Summary: Based on a comprehensive analysis of US Patent 11857443 and the published technical disclosure, a person having ordinary skill in the art would find the proposed technical variations obvious and anticipated, rendering potential patent claims covering similar technologies unpatentable under 35 U.S.C. ยง 103 due to the predictable combination of known medical device engineering techniques and standard technological progressions in endovascular hemorrhage control systems.

Original Patent Information

Patent NumberUS 11,857,443
TitleAutomated retrievable hemorrhage control system
Assignee(s)Board of Regents of the University of Nebraska